Biogaia

Biogaia Net Debt

The Net Debt of Biogaia (BIOG B.ST) as of Nov 21, 2026 is -794.41 M SEK. In the previous year, Net Debt was -1.22 B SEK — a change of -34.72% (higher).

Net Debt

-794.41 MSEK

YoY

-34.72%

Last updated:

Net Debt of Biogaia is 2025 -794.41 M SEK. Net Debt of Biogaia was 2024 -1.22 B SEK. It decreases by -34.72% higher compared to the previous year.

The Biogaia Net Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt
Date
Net Debt
Jan 1, 2018
-314.65 M SEK
Jan 1, 2019
-192.66 M SEK
Jan 1, 2020
-1.44 B SEK
Jan 1, 2021
-1.47 B SEK
Jan 1, 2022
-1.47 B SEK
Jan 1, 2023
-1.54 B SEK
Jan 1, 2024
-1.22 B SEK
Jan 1, 2025
-794.41 M SEK
The Biogaia Net Debt history
YEARNet DebtYoY
-794.41 MSEK-34.72%
-1.22 BSEK-20.74%
-1.54 BSEK+4.28%
-1.47 BSEK-0.13%
-1.47 BSEK+2.50%
-1.44 BSEK+646.54%
-192.66 MSEK-38.77%
-314.65 MSEK-9.46%
-347.50 MSEK+31.19%
-264.88 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biogaia Stock analysis

What does Biogaia do? BioGaia AB generates revenue through its probiotic product segments, primarily featuring Limosilactobacillus reuteri strains. The Paediatrics segment sells drops, gut health tablets, oral rehydration solutions, and cultures for licensee products. The Adult Health segment offers gut health tablets, oral health lozenges, and cultures integrated into dairy products by licensees. The Other segment includes royalties from development projects and revenue from CapAble's packaging solutions. Products are marketed globally to consumers seeking health benefits from probiotics, with licensees distributing branded items under agreements. The company targets health-conscious consumers through direct sales and licensed partnerships. Paediatrics products focus on infant and child health, while Adult Health products address digestive and oral wellness. CapAble, a subsidiary, contributes through packaging solutions, and royalties from development projects provide additional income streams. All segments operate under BioGaia's brand, leveraging documented health benefits of their probiotic strains. Biogaia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biogaia stock

Net Debt of Biogaia is -794.41 M SEK in 2025.

Net Debt of Biogaia changed from -1.22 B SEK to -794.41 M SEK, representing a -34.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt Biogaia since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's Biogaia historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Biogaia

All Key Metrics — Biogaia